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Introduction: 13C MRS spectroscopy in the brain in conjunction with the injection of [1,6-13C2] glucose allows a non-invasive assessment of TCA 
cycle activity and neurotransmission. Moreover mathematical models developed so far allows the differentiation of neuronal and glial compartments 
(1,2) resulting in a precious and quantitative tool in studying metabolic diseases. Unfortunately, the relatively low sensitivity in 13C detection limited in 
vivo 13C MRS usually to rat brain studies. To our knowledge only one attempt of direct detection in the mouse brain was performed in a 7 Tesla 
scanner, although metabolic fluxes were not quantified (3). With the present study, performing our acquisition at 14.1 Tesla we aim to overcome the 
above-mentioned sensitivity issue. These results could be of particular interest considering the availability of a wider range of disease models in 
genetically modified mice. 
Methods: Data were acquired in three male mice (Swiss Nude, 8 
weeks old, 28-30g) anesthetized with isoflurane (1-2%) in a voxel 
of 112μL (3.6x6.9x4.5mm3). Mice were fasted for 7 hours and 
catheterized in the tail vein for glucose infusion. The infusion 
protocol foresees an exponential decaying bolus of 99%-enriched 
[1.6-13C2] glucose during 5 minutes and a continuous infusion of 
70%-enriched glucose over 5 hours. The rate of the continuous 
infusion was adjusted in order to keep the targeted glycemia level 
(around 300mg/dL) based on bench experiments during which the 
plasma glucose level was monitored over 5 hours. Spectra were 
acquired on a 14.1T system (Varian/Magnex Scientific) using a 
home-built 9mm(13C)/15mm(1H quad) surface coil as receiver-
transmitter antenna. Direct detection of 13C nuclei was achieved by 
semi-adiabatic DEPT polarization transfer sequence(4) (TR=2.5s, 
interpulse delay of 3.8ms (optimized for JCH=130Hz), 45° for the 
last 1H pulse for the simultaneous detection of CH, CH2 and CH3 
groups). An 1H spectrum was collected prior to the injection using 
short-TE localized SPECIAL(5) sequence (TR/TE = 4000/2.8ms) on the same voxel in order to quantify the glutamate and glutamine total concentrations. 
Results and Discussion: Spectra averaged over 32 minutes acquired after 4.5 hours of [1,6-13C2] glucose infusion showed 17 well-resolved resonances 
of 13C-labeled metabolites related to glial and neuronal metabolism and neurotransmission (Fig.1). Dynamic acquisition of 13C enrichment of carbon 
positions C4,C3 and C2 of glutamate and glutamine was achieved with 10 minutes temporal resolution during 5 hours of infusion (SNR of 10-13, data 
not shown) leading to highly detailed and precise determination of fractional enrichment curves (Fig.2). The quantified metabolic fluxes using two-
compartment modeling (1,2) and the respective precision evaluated with Monte Carlo simulation are reported in the table below:  
Fluxes Vtcag Vpc Vnt Vtcan Vx 
[μmol/g/min] 0.11 ± 0.02 0.051 ± 0.005 0.21 ± 0.03 0.33 ± 0.02 0.20 ± 0.03 
 
Conclusion: We conclude that high sensitivity in direct detection of 13C labeled metabolites in vivo was achieved in the mouse brain and enabled a 
detailed two-compartment analysis of metabolic fluxes involved in energy metabolism for the first time. These results therefore open the way to a 
wide range of studies on the impact of specific brain diseases on energy metabolism in transgenic mice models. Moreover based on the obtained SNR 
we can predict that direct detection of Glu and Gln 13C resonances could reach reasonable sensitivity in a voxel size <80μL, which is of particular 
interest for localized lesions such as brain cancer.  
    
   
Fig.2: Fractional enrichment curves (n=3) of glutamate and glutamine 13C-enriched carbon positions (C4, C3 and C2) over the 5 hours of [1.6-
13C2] glucose infusion. The enrichment curves are fitted with a neuronal-glial compartmental model for the metabolic fluxes quantification. 
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Fig.1: A) In vivo 13C MRS spectrum of the mouse brain at 14.1T after 4.5 hours of [1,6-13C] 
Glucose infusion (32 min. acquisition); B) T2-weigheted image of the mouse brain with 
acquisition voxel (112μL). 
